BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 26174627)

  • 1. Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes.
    Győrffy B; Bottai G; Fleischer T; Munkácsy G; Budczies J; Paladini L; Børresen-Dale AL; Kristensen VN; Santarpia L
    Int J Cancer; 2016 Jan; 138(1):87-97. PubMed ID: 26174627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer.
    Heimes AS; Madjar K; Edlund K; Battista MJ; Almstedt K; Gebhard S; Foersch S; Rahnenführer J; Brenner W; Hasenburg A; Hengstler JG; Schmidt M
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1123-1131. PubMed ID: 28251349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical relevance of the deregulated kallikrein-related peptidase 8 mRNA expression in breast cancer: a novel independent indicator of disease-free survival.
    Michaelidou K; Ardavanis A; Scorilas A
    Breast Cancer Res Treat; 2015 Jul; 152(2):323-36. PubMed ID: 26099606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological significance and potential drug target of CDH1 in breast cancer: a meta-analysis and literature review.
    Huang R; Ding P; Yang F
    Drug Des Devel Ther; 2015; 9():5277-85. PubMed ID: 26425077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single CpG hypermethylation, allele methylation errors, and decreased expression of multiple tumor suppressor genes in normal body cells of mutation-negative early-onset and high-risk breast cancer patients.
    Böck J; Appenzeller S; Haertle L; Schneider T; Gehrig A; Schröder J; Rost S; Wolf B; Bartram CR; Sutter C; Haaf T
    Int J Cancer; 2018 Sep; 143(6):1416-1425. PubMed ID: 29659014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of methylation sites and signature genes with prognostic value for luminal breast cancer.
    Xiao B; Chen L; Ke Y; Hang J; Cao L; Zhang R; Zhang W; Liao Y; Gao Y; Chen J; Li L; Hao W; Sun Z; Li L
    BMC Cancer; 2018 Apr; 18(1):405. PubMed ID: 29642861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A seven-DNA methylation signature as a novel prognostic biomarker in breast cancer.
    Tao C; Luo R; Song J; Zhang W; Ran L
    J Cell Biochem; 2020 Mar; 121(3):2385-2393. PubMed ID: 31646666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical activity and breast cancer survival: an epigenetic link through reduced methylation of a tumor suppressor gene L3MBTL1.
    Zeng H; Irwin ML; Lu L; Risch H; Mayne S; Mu L; Deng Q; Scarampi L; Mitidieri M; Katsaros D; Yu H
    Breast Cancer Res Treat; 2012 May; 133(1):127-35. PubMed ID: 21837478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated analysis of high-resolution DNA methylation profiles, gene expression, germline genotypes and clinical end points in breast cancer patients.
    Fleischer T; Edvardsen H; Solvang HK; Daviaud C; Naume B; Børresen-Dale AL; Kristensen VN; Tost J
    Int J Cancer; 2014 Jun; 134(11):2615-25. PubMed ID: 24395279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival.
    Fleischer T; Klajic J; Aure MR; Louhimo R; Pladsen AV; Ottestad L; Touleimat N; Laakso M; Halvorsen AR; Grenaker Alnæs GI; Riis ML; Helland Å; Hautaniemi S; Lønning PE; Naume B; Børresen-Dale AL; Tost J; Kristensen VN
    Oncotarget; 2017 Jan; 8(1):1074-1082. PubMed ID: 27911866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PIK3CA expression in invasive breast cancer: a biomarker of poor prognosis.
    Aleskandarany MA; Rakha EA; Ahmed MA; Powe DG; Paish EC; Macmillan RD; Ellis IO; Green AR
    Breast Cancer Res Treat; 2010 Jul; 122(1):45-53. PubMed ID: 19701705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential involvement of RASSF2 hypermethylation in breast cancer subtypes and their prognosis.
    Perez-Janices N; Blanco-Luquin I; Torrea N; Liechtenstein T; Escors D; Cordoba A; Vicente-Garcia F; Jauregui I; De La Cruz S; Illarramendi JJ; Coca V; Berdasco M; Kochan G; Ibañez B; Lera JM; Guerrero-Setas D
    Oncotarget; 2015 Sep; 6(27):23944-58. PubMed ID: 26284587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determining the effect of DNA methylation on gene expression in cancer cells.
    Lee CJ; Evans J; Kim K; Chae H; Kim S
    Methods Mol Biol; 2014; 1101():161-78. PubMed ID: 24233782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of subtypes in human epidermal growth factor receptor 2--positive breast cancer reveals a gene signature prognostic of outcome.
    Staaf J; Ringnér M; Vallon-Christersson J; Jönsson G; Bendahl PO; Holm K; Arason A; Gunnarsson H; Hegardt C; Agnarsson BA; Luts L; Grabau D; Fernö M; Malmström PO; Johannsson OT; Loman N; Barkardottir RB; Borg A
    J Clin Oncol; 2010 Apr; 28(11):1813-20. PubMed ID: 20231686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide screen identifies a novel prognostic signature for breast cancer survival.
    Mao XY; Lee MJ; Zhu J; Zhu C; Law SM; Snijders AM
    Oncotarget; 2017 Feb; 8(8):14003-14016. PubMed ID: 28122328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel secretome-to-transcriptome integrated or secreto-transcriptomic approach to reveal liquid biopsy biomarkers for predicting individualized prognosis of breast cancer patients.
    Ankney JA; Xie L; Wrobel JA; Wang L; Chen X
    BMC Med Genomics; 2019 May; 12(1):78. PubMed ID: 31146747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Methylation Markers and Differentially Expressed Genes with Prognostic Value in Breast Cancer.
    Wu J; Zhang Y; Li M
    J Comput Biol; 2019 Dec; 26(12):1394-1408. PubMed ID: 31290690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter methylation status of the FHIT gene and Fhit expression: association with HER2/neu status in breast cancer patients.
    Jeong YJ; Jeong HY; Lee SM; Bong JG; Park SH; Oh HK
    Oncol Rep; 2013 Nov; 30(5):2270-8. PubMed ID: 23969757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of breast cancer candidate genes using gene co-expression and protein-protein interaction information.
    Yue Z; Li HT; Yang Y; Hussain S; Zheng CH; Xia J; Chen Y
    Oncotarget; 2016 Jun; 7(24):36092-36100. PubMed ID: 27150055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and biological significance of microRNA-221 in breast cancer.
    Eissa S; Matboli M; Sharawy A; El-Sharkawi F
    Gene; 2015 Dec; 574(1):163-7. PubMed ID: 26253160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.